CTRI/2021/09/036600Not yet recruitingPhase 2
Efficacy of Natroon Banjawi and Sirka as Zimad in Tinea corporis-A pilot study - Tinea corporis
Rajiv Gandhi University of Health Sciences Karnataka Bangalore0 sites0 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 2
- Status
- Not yet recruiting
- Sponsor
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patient of tinea corporis attending OPD of NIUM hospital (Confirmed by direct microscopy).
- •Patient of either gender.
- •Age group 18-60 years.
- •Patient who have agreed to sign the informed consent form, comply with the study procedure, and availability for regular follow up during the protocol.
Exclusion Criteria
- •Patient below 18 years and above 60 years of age
- •Patient with sever systemic illness like Diabetic, malignancy etc
- •HIV/AIDS or other immunocompromised patients
- •Patient with other skin diseases like Erythrasma, Candida intertrigo, Intertriginous Psoriasis, Pityriasis versicolor.
Investigators
Similar Trials
Not yet recruiting
Phase 2
treatment of qooba (tinea cruris) with unani formulationsCTRI/2020/03/023861ational Institute of Unani Medicine
Not yet recruiting
Phase 3
Effect of Ayurvedic treatment in the management of delayed mensesCTRI/2024/05/066863Institute of Teaching and Research in Ayurveda
Not yet recruiting
Phase 2
Efficacy of dry cupping in tension-type headacheCTRI/2021/03/031706ational Institute Of Unani Medicine
Not yet recruiting
Phase 2
Management of Avabahuka with special reference to frozen shoulder through Ayurveda.CTRI/2019/03/018086ational Institute of Ayurveda Jaipur
Not yet recruiting
Phase 2
nani formulation for Chronic EczemaCTRI/2021/01/030759ATIONAL INSTITUTE OF UNANI MEDICINE